Adherence to oral contraception in women on Category X medications

American Journal of Medicine

Volumn 123, Issue 10, 2010, Pages

  Steinkellner, Amy ^a   Chen, William ^a   Denison, Shannon E ^a  

^a Medco Health Solutions   (United States)

Author keywords

Category X; Contraception oral; Medication adherence; Teratogenic

Indexed keywords

ORAL CONTRACEPTIVE AGENT; TERATOGENIC AGENT;

ADULT; AGE; ARTICLE; CATEGORY X MEDICATION; CHRONIC DISEASE; DRUG CLASSIFICATION; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PATIENT COMPLIANCE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; ADOLESCENT; CHI SQUARE DISTRIBUTION; INCOME; MEDICATION COMPLIANCE; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INCOME; LOGISTIC MODELS; MEDICATION ADHERENCE; SOCIOECONOMIC FACTORS; TERATOGENS; YOUNG ADULT;

EID: 77957785796     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.05.009     Document Type: Article

References (26)

1. E.B. Schwarz, J. Maselli, M. Norton, and R. Gonzales Prescription of teratogenic medications in United States ambulatory practices Am J Med 118 2005 1240 1249
2. US Food and Drug Administration Code of Federal Regulation, Title 21 Fed Regist 21 1 2003 21 32 21 C.F.R. Section 201.57
3. S.E. Andrade, M.A. Raebel, and A.N. Morse Use of prescription medications with a potential for fetal harm among pregnant women Pharmacoepidemiol Drug Saf 15 2006 546 554
4. A. Addis, S. Sharabi, and M. Bonati Risk classification systems for drug use during pregnancy Are they a reliable source of information? Drug Saf 3 2000 245 253
5. K.L. Daniel, K.D. Goldman, S. Lachenmayr, J.D. Erickson, and C. Moore Interpretations of a teratogen warning symbol Teratology 64 2001 148 153
6. E.B. Schwarz, A. Santucci, S. Borrero, A.Y. Akers, C. Nikolajski, and M.A. Gold Perspectives of primary care clinicians on teratogenic risk counseling Birth Defects Res A Clin Mol Teratol 85 2009 858 863
7. A.K. Santucci, M.A. Gold, A.Y. Akers, S. Borrero, and E.B. Schwarz Women's perspectives on counseling about risks for medication-induced birth defects Birth Defects Res A Clin Mol Teratol 88 1 2010 64 69
8. E.B. Schwarz, D.A. Postlethwaite, Y. Hung, and M.A. Armstrong Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women Ann Intern Med 147 6 2007 370 376
9. M.A. Raebel, J.L. Ellis, and S.E. Andrade Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data Pharmacoepidemiol Drug Saf 14 2005 829 836
10. M.B. Forrester, and S.K. Stanley Exposures and treatments among women of childbearing age and pregnant women reported to Texas poison centers Vet Hum Toxicol 46 4 2004 210 212
11. K. Kost, S. Singh, B. Vaughan, J. Trussell, and A. Bankole Estimates of contraceptive failure from the 2002 national survey of family growth Contraception 77 2008 10 21
12. Halpern V, Grimes DA, Lopez LM, Gallo MF. Strategies to improve adherence and acceptability of hormonal METHODS: of contraception. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004317. DOI: 10.1002/14651858. CD004317.pub2.
13. A.L. Nelson, C. Westhoff, and S.M. Schnare Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation Obstet Gynecol 112 4 2008 782 787
14. J.J. Frost, J.E. Darroch, and L. Remez Improving contraceptive use in the United States Issues Brief (Alan Guttmacher Inst) 1 2008 1 8
15. DRUGDEX® System (electronic version). Thomson Reuters (Healthcare) Inc., Greenwood Village, Colorado, USA http://www.thomsonhc.com Accessed September 19, 2009
16. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2009 http://www.clinicalpharmacology.com Accessed September 19, 2009
17. J.D. Homco, J.F. Peipert, G.M. Secura, V.A. Lewis, and J.E. Allsworth Reasons for ineffective pre-pregnancy contraception use in patients seeking abortion services Contraception 80 2009 569 574
18. J.J. Frost, and J.E. Darroch Factors associated with contraceptive choice and inconsistent method use, United States, 2004 Perspect Sex Reprod Health 40 2 2008 94 104
19. T.C. Davis, M.S. Wolf, and P.F. Bass Literacy and misunderstanding prescription drug labels Ann Intern Med 145 2006 887 894
20. M.V. Williams, R.M. Parker, and D.W. Baker Inadequate functional health literacy among patients at two public hospitals JAMA 274 21 1995 1677 1682
21. J.A. Gazmararian, D.W. Baker, and M.V. Williams Health literacy among Medicare enrollees in a managed care organization JAMA 281 1999 545 551
22. P.A. Lohr, E.B. Schwarz, J.E. Gladstein, and A.L. Nelson Provision of contraceptive counseling by internal medicine residents J Womens Health (Larchmt) 18 2009 127 131
23. C.S. Weisman, D.S. Maccannon, J.T. Henderson, E. Shortridge, and C.L. Orso Contraceptive counseling in managed care: preventing unintended pregnancy in adults Women's Health Issues 12 2 2002 79 95
24. L. James, T.R.E. Barnes, and P. Lelliott Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists J Psychopharmacol 21 8 2007 815 819
25. J. Steinauer, F. LaRochelle, M. Rowh, L. Backus, Y. Sandahl, and A. Foster First impressions: what are preclinical medical students in the US and Canada learning about sexual and reproductive health? Contraception 80 2009 74 80
26. P. Aspden, J. Wolcott, J.L. Bootman, and L.R. Cronenwett Preventing Medication Errors: Quality Chasm Series 2007 National Academies Press Washington, DC